nonhuman
primat
nhp
use
model
human
diseas
owe
remark
similar
genom
physiolog
immun
system
recent
increas
interest
model
tuberculosi
tb
nhp
macaqu
suscept
infect
differ
strain
mycobacterium
tuberculosi
mtb
produc
full
spectrum
diseas
condit
includ
latent
infect
chronic
progress
infect
acut
tb
depend
rout
dose
infect
clearli
nhp
excel
model
human
tb
initi
aim
nhp
model
allow
preclin
test
candid
vaccin
drug
also
use
studi
pathogenesi
immun
correl
protect
recent
advanc
field
discuss
review
key
question
effect
hypoxia
biolog
mtb
basi
reactiv
latent
tb
investig
use
model
tb
studi
guinea
pig
sinc
time
koch
centuri
infect
guinea
pig
produc
symptom
patholog
similar
human
use
model
chemotherapi
vaccin
howev
anim
exhibit
exquisit
suscept
diseas
rabbit
also
employ
model
tb
model
faith
repres
pathophysiolog
aspect
tb
infect
particular
studi
cavitari
lesion
howev
limit
avail
molecular
immunolog
research
resourc
model
repres
challeng
mous
util
model
tb
extens
util
studi
bacteri
factor
virul
also
contribut
tremend
understand
immun
protect
mechan
control
mtb
infect
addit
tool
molecular
immunolog
research
avail
defin
transgen
knockout
mice
render
murin
model
invalu
howev
mous
model
shortcom
classic
latent
infect
repres
immunolog
respons
infect
absenc
clinic
microbiolog
evid
diseas
attain
mous
model
moreov
gross
microscop
patholog
murin
tb
significantli
differ
tb
human
major
drawback
differ
host
respons
reflect
histopatholog
lesion
predict
present
differ
challeng
vari
degre
vivo
stress
mtb
thu
result
vari
respons
pathogen
differ
outcom
infect
fish
infect
mycobacterium
marinum
recent
emerg
excel
surrog
model
studi
mtb
infect
infect
zebrafish
gener
granulomat
lesion
infect
zebrafish
embryo
transpar
allow
emerg
granulomat
patholog
visual
assay
real
time
coupl
rel
eas
perform
host
genet
zebrafish
render
fishm
marinum
model
attract
studi
factor
respons
bacteri
pathogenesi
host
immun
nonhuman
primat
genom
physiolog
immunolog
similar
human
attract
model
wide
rang
infecti
diseas
nhp
model
aid
significantli
contribut
understand
aid
pathogenesi
includ
viral
latenc
develop
vaccin
therapeut
microbicid
prevent
hiv
transmiss
addit
nhp
model
util
studi
malaria
varieti
infecti
agent
smallpox
ebola
venezuelan
equin
enceph
nipah
marburg
sar
parainfluenza
virus
pneumocystisaid
coinfect
b
anthraci
mansoni
c
tracomati
l
monocytogen
groupa
streptococcu
leismania
coxiella
burnetti
burkholderia
pseudomallei
kaushal
mehra
c
j
roy
unpublish
data
common
element
studi
similar
biolog
speci
model
human
model
nhp
result
recapitul
key
aspect
diseas
occur
human
experiment
model
tb
infect
describ
contribut
immens
understand
variou
phase
mtb
infect
result
host
respons
howev
wide
believ
none
model
reason
reproduc
classic
latenc
variou
type
patholog
lesion
observ
human
infect
moreov
lack
suffici
repertoir
molecular
immunolog
reagent
model
limit
use
light
nhp
model
tb
gain
import
last
decad
crucial
advantag
nhp
model
tb
abil
gener
clinic
correl
infect
exampl
blood
cbc
count
chemistri
serum
creactiv
protein
differenti
centrifug
valu
thorac
xray
tuberculin
skin
test
interferon
gamma
releas
assay
gener
agre
primat
robustli
reproduc
infect
mtb
gener
sever
aspect
humanlik
diseas
includ
protect
vaccin
bacil
calmetteguerin
bcg
much
work
perform
indian
rhesu
macaqu
macaca
mulatta
reduc
avail
speci
polit
reason
recruit
model
aid
research
coupl
assumpt
infecti
diseas
gener
tb
particular
wane
contribut
declin
interest
macaqu
model
tb
modern
era
pioneer
work
walsh
et
al
reinvigor
interest
nhp
model
tb
recent
work
nhp
model
tb
primarili
util
either
cynomolgu
macaqu
macaca
fasciculari
philippin
mauritian
origin
captiv
bread
rhesu
macaqu
macaca
mulatta
indian
chines
origin
signific
advanc
field
summar
tabl
import
variabl
inoculum
dose
rout
infect
strain
mtb
use
also
list
tabl
part
studi
macaqu
routin
infect
mtb
strain
erdman
tabl
inocul
typic
use
either
intratrach
instil
use
bronchoscop
true
headonli
aerosol
deliveri
method
advantag
method
employ
former
method
rel
easi
consist
quantit
deliv
dose
inocula
difficult
achiev
via
aerosol
method
due
fact
nhp
expens
unlik
mice
euthan
day
aim
identifi
initi
inocula
therefor
techniqu
wholebodi
plethysmographi
use
conjug
aerosol
deliveri
accur
identifi
anim
breath
rate
voidal
volum
hand
aerosol
deliveri
mtb
accur
mimic
natur
infect
human
be
intratrach
deposit
local
one
lobe
aerosol
rout
infect
initi
lobe
lung
cynomolgu
macaqu
infect
low
dose
colonyform
unit
cfu
virul
mtb
erdman
strain
via
intratrach
rout
gener
spectrum
tb
diseas
condit
base
choic
dose
rel
infecti
strain
high
dose
mtb
erdman
strain
cfu
instil
trachea
result
acut
fatal
tubercul
pneumonia
cynomolgu
macaqu
moder
dose
mtb
erdman
cfu
deliv
via
ident
rout
led
develop
local
slowli
progress
tb
major
anim
tabl
extrem
low
dose
cfu
mtb
erdman
caus
anim
maintain
infect
subclin
latent
state
long
period
time
similar
result
speci
obtain
later
studi
onethird
anim
infect
low
dose
cfu
mtb
erdman
strain
fail
develop
clinic
sign
diseas
studi
spite
sign
infect
thu
mirror
human
popul
latent
infect
mtb
model
gross
granulomat
lesion
observ
earli
week
postinfect
character
extens
necrosi
adapt
immun
respons
character
product
could
discern
week
infect
subsequ
detail
descript
lung
patholog
use
ident
strain
dose
mtb
point
spectrum
granulomat
lesion
primari
well
postprimari
lung
anim
akin
observ
chronic
infect
human
model
sinc
util
studi
effect
candid
antitubercular
vaccin
vari
degre
success
recent
model
also
use
explor
central
role
tumor
necrosi
factor
tnf
control
latent
tb
infect
studi
whether
regulatori
cell
play
role
process
macaqu
also
use
model
reactiv
latent
mtb
infect
use
antitnf
antibodi
neutral
tnf
activ
coinfect
simian
immunodefici
viru
siv
model
tbaid
coinfect
human
popul
tabl
initi
believ
rhesu
macaqu
exhibit
latent
phase
mtb
infect
notion
stem
fact
compar
bcg
vaccin
even
appear
better
protect
cynomolgu
rather
rhesu
macaqu
challeng
highli
virul
mtb
erdman
howev
recent
data
research
institut
point
rhesu
macaqu
protect
mtb
erdman
bcg
vaccin
accept
rhesu
macaqu
much
like
cynomolgu
develop
asymptomat
chronic
latent
acut
rapidli
fatal
pulmonari
tb
follow
infect
appropri
dose
mtb
tabl
much
earlier
work
rhesu
macaqu
util
vaccin
strain
bcg
mycobacteri
infect
agent
studi
high
dose
bcg
low
dose
moder
dose
high
dose
employ
simultan
coinfect
siv
perform
result
high
dose
bcg
simultan
coinfect
immunodeficiencyinduc
viral
agent
bcg
abl
gener
tblike
diseas
possibl
studi
reactiv
progress
diseas
model
laid
foundat
signific
studi
role
cell
immun
control
mtb
infect
tabl
infect
via
aerosol
rout
establish
rhesu
macaqu
model
allow
natur
deposit
infect
bacilli
onto
pulmonari
surfac
howev
aerosol
rout
challeng
administr
extrem
low
cfu
infect
macaqu
use
mtb
strain
reduc
pathogen
exampl
allow
develop
model
human
tb
macaqu
expos
moder
number
viabl
bacilli
via
inhal
rout
result
latent
chronic
rather
acut
diseas
outcom
rhesu
macaqu
model
also
use
test
efficaci
safeti
numer
antitubercular
vaccin
candid
shown
beyond
doubt
bcgvaccin
rhesu
macaqu
exhibit
protect
diseas
new
result
clarifi
confus
exist
past
high
suscept
mtb
infect
low
level
protect
follow
bcg
vaccin
rhesu
rel
cynomolgu
tabl
definit
anim
model
complet
mimic
human
diseas
particularli
true
tb
present
remark
differ
diseas
base
strain
virul
host
genet
varieti
confound
environment
factor
howev
mtbinfect
macaqu
offer
signific
advantag
model
key
aspect
human
tb
macaqu
develop
true
humanlik
latent
infect
character
absenc
clinic
sign
infect
presenc
antigenspecif
immunolog
respons
measur
tuberculin
skin
test
tst
releas
assay
igra
develop
specif
primat
primagam
clinic
radiolog
diagnost
mean
assess
mtb
infect
well
develop
nhp
compar
human
discuss
earlier
one
key
advantag
macaqu
model
abil
recapitul
complet
spectrum
granulomat
lesion
occur
human
diseas
shown
fig
rhesu
macaqu
infect
mtb
classic
lesion
central
caseou
necrot
core
commonli
found
fig
howev
type
lesion
fibrot
fig
cavitari
fig
may
also
present
albeit
rare
case
miner
calcif
caseou
lesion
also
observ
fig
often
caseou
lesion
also
exhibit
format
numer
multinucl
giant
cell
peripher
region
fig
rhesu
macaqu
coinfect
siv
postprimari
lesion
readili
observ
vicin
primari
lesion
fig
result
strongli
reinforc
point
macaqu
model
tb
recapitul
wide
varieti
patholog
tb
lesion
observ
infect
human
macaqu
model
describ
review
possibl
reactiv
latent
chronic
tb
acut
form
character
rapid
multipl
bacilli
pneumonia
use
either
siv
coinfect
blockad
pathway
coinfect
aid
major
reason
global
resurg
tb
last
sever
decad
expect
robust
tbaid
coinfect
model
use
mtb
bcg
siv
allow
preclin
test
therapeut
vaccin
also
lend
insight
molecular
cellular
mechan
reactiv
typic
coinfect
rhesu
cynomolgu
macaqu
alreadi
latent
chronic
infect
mtb
via
either
aerosol
intratrach
rout
perform
inocul
siv
siv
intraven
rhesu
macaqu
dose
tcid
appear
suffici
reactiv
chronic
tb
requir
dosag
may
higher
cynomolgu
macaqu
siv
mac
virus
host
adapt
rhesu
macaqu
recent
possibl
identifi
lung
well
lymph
node
cell
coinfect
rhesu
macaqu
harbor
mtb
siv
recent
identifi
coinfect
cell
lung
macrophag
multilabel
confoc
microscopi
coloc
cell
typespecif
tbspecif
antigen
cell
mehra
et
al
unpublish
data
novel
observ
biolog
tbaid
coinfect
imposs
gener
model
besid
natur
host
macaqu
model
also
provid
advantag
studi
mtbhiv
coinfect
human
includ
limit
defin
time
infect
control
dose
deliveri
method
mtb
siv
includ
avail
defin
gene
delet
mutant
siv
mtb
abil
collect
longitudin
sampl
control
environment
dietari
social
factor
futur
import
studi
whether
coinfect
macrophag
lung
defici
control
bacteri
replic
last
year
sever
novel
applic
incorpor
nhp
model
tb
abil
infect
nhp
via
inhal
aerosol
rout
one
exampl
conceiv
abil
use
natur
rout
nhp
model
would
similar
posit
impact
tb
research
abil
infect
mice
via
aerosol
rout
two
decad
ago
sever
nhp
studi
use
thorac
radiographi
imag
determin
progress
extent
tb
nhp
howev
stateoftheart
imag
tool
appli
nhp
model
major
advanc
occur
lewinsohn
et
al
employ
xray
comput
tomographi
ct
scan
captur
highresolut
realtim
imag
lung
lesion
rhesu
macaqu
infect
high
dose
mtb
result
significantli
correl
pulmonari
histopatholog
thu
provid
accur
yet
noninvas
assess
lesion
develop
diseas
progress
flynn
et
al
use
positron
emiss
tomographi
pet
coupl
ct
petct
enabl
assess
function
pet
structur
ct
aspect
develop
progress
pulmonari
granulomat
lesion
jl
flynn
person
commun
use
technolog
research
differenti
lesion
potenti
reactiv
mtb
replic
truli
latent
clearli
advanc
imag
technolog
use
assess
protect
efficaci
candid
vaccin
therapeut
potenti
candid
drug
mtb
encod
differ
open
read
frame
signific
number
gene
defin
homolog
speci
therefor
difficult
assign
function
mani
gene
research
resort
use
mtb
mutant
librari
defin
gene
absolut
requir
pathogenesi
vitro
vivo
use
murin
model
laboratori
recent
appli
approach
rhesu
model
mix
pool
defin
distinct
mtb
mutant
use
infect
rhesu
macaqu
via
aerosol
rout
infect
phenotyp
studi
use
microarraybas
surviv
readout
found
acut
tb
mutant
test
attenu
surviv
multipl
macaqu
stark
contrast
mutant
test
mice
significantli
lower
number
mutant
attenu
conceiv
better
structur
organ
nhp
tb
lesion
contribut
effect
robust
immun
respons
abl
clear
mutant
lack
certain
protein
requir
pathogen
surviv
vivo
studi
identifi
potenti
novel
bacteri
pathway
could
target
antimtb
drug
develop
dna
repair
molybdenum
biosynthesi
believ
human
tb
lesion
evolv
highli
necrot
center
fill
debri
cellular
content
destroy
infect
macrophag
lesion
matur
time
environ
becom
hypox
specul
hypoxia
must
signific
effect
biolog
pathogen
primarili
mtb
known
mount
signific
transcript
respons
chang
oxygen
concentr
govern
transcript
factor
dosr
via
sensor
kinas
dost
doss
hypothesi
test
analyz
lesion
obtain
macaqu
infect
mtb
pimonidazol
hydrochlorid
imag
agent
bioreduct
activ
specif
hypox
environ
inject
macaqu
prior
necropsi
discret
region
exhibit
activ
pimonidazol
adduct
central
caseou
region
tubercular
granuloma
evid
clearli
confirm
nhp
lesion
hypox
experi
begin
provid
tool
examin
role
local
microenviron
mtb
biolog
virul
vivo
genomewid
system
biolog
approach
extens
use
studi
biolog
problem
last
decad
includ
transcriptomeand
proteomewid
investig
recent
approach
appli
nhp
model
tb
first
studi
employ
rhesu
macaquespecif
wholegenom
microarray
studi
host
gene
express
tubercul
lesion
obtain
lung
infect
anim
acut
chronic
stage
infect
result
indic
chang
mtb
biolog
rapidli
modul
host
granuloma
environ
initi
type
gene
express
signatur
give
way
antiinflammatori
gene
express
marker
recent
macaqu
transcriptom
also
use
identifi
pathogenspecif
gene
express
signatur
peripher
blood
expect
sever
studi
report
near
futur
anoth
advantag
nhp
model
rapidli
grow
avail
rhesu
cynomolgu
macaqu
genom
sequenc
similar
human
genom
expect
recent
futur
mhc
type
data
infect
macaqu
allow
us
valid
resist
suscept
hypothes
deriv
analys
human
popul
interest
nhp
model
tb
stem
accur
portray
key
aspect
human
syndrom
model
initi
develop
focu
preclin
test
diagnost
therapeut
vaccin
candid
aim
remain
import
nhp
model
appear
extrem
valuabl
studi
pathogenesi
includ
host
bacteri
determin
diseas
immun
protect
particular
think
model
crucial
examin
tbaid
coinfect
reactiv
tb
gener
model
also
use
design
comput
model
tb
latenc
reactiv
reinfect
base
macaqu
respons
differ
type
mtb
infect
key
question
relat
mtb
virul
also
address
model
includ
effect
hypoxia
pathogen
longterm
surviv
abil
mtb
reprogram
metabol
adapt
lung
environ
nutrient
avail
therein
product
adapt
respons
unabl
provid
steril
immun
mtb
modul
host
immun
respons
benefit
